Transmission of neurodegenerative disorders through blood transfusion: A cohort study

Annals of Internal Medicine

Volumn 165, Issue 5, 2016, Pages 316-324

  Edgren, Gustaf ^a   Hjalgrim, Henrik ^b   Rostgaard, Klaus ^b   Lambert, Paul ^c   Wikman, Agneta ^d   Norda, Rut ^e   Titlestad, Kjell Einar ^f   Erikstrup, Christian ^g   Ullum, Henrik ^h   Melbye, Mads ^b   Busch, Michael P ⁱ   Nyrén, Olof ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STATENS SERUM INSTITUT   (Denmark)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e UPPSALA UNIVERSITY   (Sweden)

^f ODENSE UNIVERSITY HOSPITAL   (Denmark)

^g AARHUS UNIVERSITY HOSPITAL   (Denmark)

^h Mental Health Services CPH   (Denmark)

ⁱ BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BLOOD COMPONENT; BLOOD DONOR; BLOOD TRANSFUSION; CHRONIC HEPATITIS; COHORT ANALYSIS; CONTROLLED STUDY; DEGENERATIVE DISEASE; DEMENTIA; DENMARK; DISEASE TRANSMISSION; FEMALE; FOLLOW UP; HEPATITIS C VIRUS; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SWEDEN; VIRUS DETECTION; ADVERSE EFFECTS; HEPATITIS, VIRAL, HUMAN; INCIDENCE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; RISK;

AGED; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BLOOD TRANSFUSION; DEMENTIA; DENMARK; FEMALE; HEPATITIS, VIRAL, HUMAN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE; RETROSPECTIVE STUDIES; RISK; SWEDEN;

EID: 84985993118     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M15-2421     Document Type: Article

References (38)

1. Lee SJ, Desplats P, Sigurdson C, Tsigelny I, Masliah E. Cell-to-cell transmission of non-prion protein aggregates. Nat Rev Neurol. 2010; 6:702-6. [PMID: 21045796] doi:10.1038/nrneurol.2010.145.
2. Morales R, Duran-Aniotz C, Castilla J, Estrada LD, Soto C. De novo induction of amyloid-ß deposition in vivo. Mol Psychiatry. 2012;17: 1347-53. [PMID: 21968933] doi:10.1038/mp.2011.120.
3. Prusiner SB. Cell biology. A unifying role for prions in neurodegenerative diseases. Science. 2012;336:1511-3. [PMID: 22723400] doi:10.1126/science.1222951.
4. Mü nch C, O'Brien J, Bertolotti A. Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc Natl Acad Sci U S A. 2011;108:3548-53. [PMID: 21321227] doi:10.1073/pnas.1017275108.
5. Grad LI, Yerbury JJ, Turner BJ, Guest WC, Pokrishevsky E, O'Neill MA, et al. Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms. Proc Natl Acad Sci U S A. 2014;111: 3620-5. [PMID: 24550511] doi:10.1073/pnas.1312245111.
6. Jucker M, Walker LC. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature. 2013;501:45-51. [PMID: 24005412] doi:10.1038/nature12481.
7. Sanders DW, Kaufman SK, DeVos SL, Sharma AM, Mirbaha H, Li A, et al. Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron. 2014;82:1271-88. [PMID: 24857020] doi:10.1016/j.neuron.2014.04.047.
8. Polymenidou M, Cleveland DW. The seeds of neurodegeneration: prion-like spreading in ALS. Cell. 2011;147:498-508. [PMID: 22036560] doi:10.1016/j.cell.2011.10.011.
9. Kim J, Holtzman DM. Medicine. Prion-like behavior of amyloidbeta. Science.2010;330:918-9.[PMID:21071652]doi:10.1126/science.1198314.
10. Frost B, Diamond MI. Prion-like mechanisms in neurodegenerative diseases. Nat Rev Neurosci. 2010;11:155-9. [PMID: 20029438] doi:10.1038/nrn2786.
11. Olanow CW, Stern MB, Sethi K. The scientific and clinical basis for the treatment of Parkinson disease (2009). Neurology. 2009;72: S1-136. [PMID: 19470958] doi:10.1212/WNL.0b013e3181a1d44c.
12. Frost B, Jacks RL, Diamond MI. Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem. 2009;284: 12845-52. [PMID: 19282288] doi:10.1074/jbc.M808759200.
13. Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser S, Schaefer C, Kilger E, et al. Exogenous induction of cerebral betaamyloidogenesis is governed by agent and host. Science. 2006;313: 1781-4. [PMID: 16990547].
14. Ridley RM, Baker HF, Windle CP, Cummings RM. Very long term studies of the seeding of beta-amyloidosis in primates. J Neural Transm (Vienna). 2006;113:1243-51. [PMID: 16362635].
15. Baker HF, Ridley RM, Duchen LW, Crow TJ, Bruton CJ. Induction of beta (A4)-amyloid in primates by injection of Alzheimer's disease brain homogenate. Comparison with transmission of spongiform encephalopathy. Mol Neurobiol. 1994;8:25-39. [PMID: 8086126].
16. Luk KC, Kehm V, Carroll J, Zhang B, O'Brien P, Trojanowski JQ, et al. Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science. 2012;338:949- 53. [PMID: 23161999] doi:10.1126/science.1227157.
17. Clavaguera F, Akatsu H, Fraser G, Crowther RA, Frank S, Hench J, et al. Brain homogenates from human tauopathies induce tau inclusions in mouse brain. Proc Natl Acad Sci U S A. 2013;110:9535- 40. [PMID: 23690619] doi:10.1073/pnas.1301175110.
18. Eisele YS, Obermü ller U, Heilbronner G, Baumann F, Kaeser SA, Wolburg H, et al. Peripherally applied Aβ-containing inoculates induce cerebral β-amyloidosis. Science. 2010;330:980-2. [PMID: 20966215] doi:10.1126/science.1194516.
19. Houston F, Foster JD, Chong A, Hunter N, Bostock CJ. Transmission of BSE by blood transfusion in sheep [Letter]. Lancet. 2000;356: 999-1000. [PMID: 11041403].
20. Llewelyn CA, Hewitt PE, Knight RS, Amar K, Cousens S, Mackenzie J, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet. 2004;363:417-21. [PMID: 14962520].
21. Wroe SJ, Pal S, Siddique D, Hyare H, Macfarlane R, Joiner S, et al. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: A case report. Lancet. 2006;368:2061-7. [PMID: 17161728].
22. Jaunmuktane Z, Mead S, Ellis M, Wadsworth JD, Nicoll AJ, Kenny J, et al. Evidence for human transmission of amyloid-ß pathology and cerebral amyloid angiopathy. Nature. 2015;525:247-50. [PMID: 26354483] doi:10.1038/nature15369.
23. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al; Alzheimer's Disease International. Global prevalence of dementia: A Delphi consensus study. Lancet. 2005;366:2112-7. [PMID: 16360788].
24. Rodríguez-Leyva I, Calderó n-Garcidueñ as AL, Jimé nez- Capdeville ME, Rentería-Palomo AA, Hernandez-Rodriguez HG, Valdé s-Rodríguez R, et al. α-Synuclein inclusions in the skin of Parkinson's disease and parkinsonism. Ann Clin Transl Neurol. 2014;1: 471-8. [PMID: 25356418] doi:10.1002/acn3.78.
25. Rodriguez-Leyva I, Chi-Ahumada E, Calderon-Garcidueñ as AL, Medina-Mier V, Martel-Gallegos G, Zarazua S, et al. Skin cells express altered proteins that characterize the most common neurodegenerative diseases. Neurology. 2015;83(Suppl 14).
26. Kamper-Jørgensen M, Edgren G, Rostgaard K, Biggar RJ, Nyré n O, Reilly M, et al. Blood transfusion exposure in Denmark and Sweden. Transfusion. 2009;49:888-94. [PMID: 19210324] doi:10.1111/j.1537-2995.2008.02081.x.
27. Edgren G, Rostgaard K, Vasan SK, Wikman A, Norda R, Pedersen OB, et al. The new Scandinavian Donations and Transfusions database (SCANDAT2): A blood safety resource with added versatility. Transfusion. 2015;55:1600-6. [PMID: 25573303]doi:10.1111/trf.12986.
28. Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24:659-67. [PMID: 19504049] doi:10.1007/s10654-009-9350-y.
29. Schmidt M, Pedersen L, Sørensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29: 541-9. [PMID: 24965263] doi:10.1007/s10654-014-9930-3.
30. Edgren G, Hjalgrim H, Reilly M, Tran TN, Rostgaard K, Shanwell A, et al. Risk of cancer after blood transfusion from donors with subclinical cancer: A retrospective cohort study. Lancet. 2007;369:1724- 30. [PMID: 17512857].
31. Hjalgrim H, Rostgaard K, Vasan SK, Ullum H, Erikstrup C, Pedersen OB, et al. No evidence of transmission of chronic lymphocytic leukemia through blood transfusion. Blood. 2015;126:2059-61. [PMID: 26302757] doi:10.1182/blood-2015-03-632844.
32. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med. 1996;334:1685-90. [PMID: 8637512].
33. Hinchliffe SR, Lambert PC. Flexible parametric modelling of cause-specific hazards to estimate cumulative incidence functions. BMC Med Res Methodol. 2013;13:13. [PMID: 23384310] doi:10.1186/1471-2288-13-13.
34. Douet JY, Zafar S, Perret-Liaudet A, Lacroux C, Lugan S, Aron N, et al. Detection of infectivity in blood of persons with variant and sporadic Creutzfeldt-Jakob disease. Emerg Infect Dis. 2014;20: 114-7. [PMID: 24377668] doi:10.3201/eid2001.130353.
35. Jin YP, Gatz M, Johansson B, Pedersen NL. Sensitivity and specificity of dementia coding in two Swedish disease registries. Neurology. 2004;63:739-41. [PMID: 15326258].
36. Phung TK, Andersen BB, Høgh P, Kessing LV, Mortensen PB, Waldemar G. Validity of dementia diagnoses in the Danish hospital registers. Dement Geriatr Cogn Disord. 2007;24:220-8. [PMID: 17690555].
37. Greenland S, Lash TL. Disease misclassification. In: Rothman KJ, Greenland S, Lash TL, eds. Modern Epidemiology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2008:358-9.
38. Dorsey K, Zou S, Schonberger LB, Sullivan M, Kessler D, Notari E 4th, et al. Lack of evidence of transfusion transmission of Creutzfeldt- Jakob disease in a US surveillance study. Transfusion. 2009;49:977- 84. [PMID: 19170987] doi:10.1111/j.1537-2995.2008.02056.x.